RSS

Issue 6

EPM speaks to Kirsty Gapp, 3M Drug Delivery Systems about the challenges and trends within the industry and why interest in microneedle technology is surging. Read more

Latest Issue

In this article, Chris Gale, vice president, Greentarget, talks pharma, wearables and the necessity of community to make it all work. Read more

Opinion

Mike Novotny, founder and CEO of Medrio, discusses the considerations of using digital technology within clinical trials. Read more

Opinion

This time in Tech Talk, Dr Neil Polwart, Novarum founder and BBI Group head of mobile, looks at blockchain technology in mHealth. Read more

Opinion

In this interview, Simon Cole, sales executive at Atlantic Zeiser UK, points out why blockchain is gaining importance in track & trace systems, and what effects can be expected from Brexit. Read more

Opinion

The September issue of @EPM_magazine is available for download with all the regulars and features on artificial intelligence, formulation, analytical lab techniques, artificial intelligence, APIs/HPAPIs plus a serialisation supplement. Read more

Latest Issue

John Rush subject matter expert — HVAC, from specialist cleanroom design and construction provider BES, discusses strategies for designing more energy efficient cleanrooms. Read more

Opinion

Andrew Ramage, microbiology product specialist, Cherwell Laboratories, puts outsourcing of microbiological growth media under the microscope revealing the benefits and what makes an ideal media manufacturer. Read more

Latest Issue

Not all highly potent compounds require extreme containment. In this article, Jeff Pavlovich, senior process safety engineer at Cambrex Charles City, examines the intricacies of risk assessment and the importance of a realistic approach. Read more

Latest Issue

Here, Rob Harris, chief technical officer, and Matt Ling, technical director, Juniper Pharma Services, explains why modelling can help to minimise the risks associated with the development of poorly soluble drugs. Read more

, Latest Issue

As we draw ever nearer to the time that compliance with the European Falsified Medicines Directive (FMD) is required, we discuss the value of serialisation beyond compliance and outsourcing with six leading solutions providers. Read more

Latest Issue

In this article, Stephie Lee, scientist, Oral Drug Delivery at Catalent Pharma Solutions, goes through the important considerations for a successful GLP toxicology study outcome. Read more

Latest Issue

As the EU Falsified Medicines Directive deadline nears, CMOs & CPOs should embrace tech solutions that add serialisation return on investment. David Carpentier, founding partner & CTO for Adents, tell us more. Read more

Latest Issue

In the run up to the European Falsified Medicines Directive Markus Rosenkranz, leader Serialisation Solutions, Rockwell Automation EMEA, discusses how best to meet the interoperability challenges head on and drive return on investment. Read more

Latest Issue

As we go further down ‘the rabbit hole’ in terms of technological advancements, we discuss augmented reality and its uses for pharma manufacturers with Jean-Yves Balfin, product manager at Korsch. Read more

Latest Issue

As part of our feature on serialisation, Joseph L Lipari, director, Cloud Implementation Services, Systech International, reveals the importance of blockchain in closing the supply chain trust gap. Read more

Opinion

According to Frank Austin Nothaft, GTM lead for Genomics, Databricks, a unified approach to big data is the best way to get the most value. Here, he tells us more. Read more

Opinion

Here, Dr Natasha Varvogli, intellectual property consultant, and Maria Andrielou, marketing & communication at VIO Chemicals, look at patents and their role in the pharma industry. Read more

Opinion

This feature co-written by The National Institute for Bioprocessing Research and Training and Thermo Fisher Scientific looks at how the latest tools are taking the complexity out of peptide mappings workflows. Read more

, News

Machine learning offers considerable potential for streamlining and transforming routine information processes in life sciences — but could more creative applications of artificial intelligence take things further still? AMPLEXOR’s Siniša Belina asse Read more

Opinion